GEROPHARM is one of the leaders in the field of biotechnology products used for diabetes treatment. Company is specializing in full-cycle drug development and production of insulin products (rh-insulins, insulin glargine, lispro & lispro mix, aspart & aspart mix, degludec). GEROPHARM expertise also covers neurology, ophthalmology, endocrinology and gynecology therapeutic areas. GEROPHARM production facilities (two manufacturing plants) fully comply with ISO 9001 and GMP standard.

Sales Markets

Middle East Region (e.g. UAE); Africa; Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)

Meet us at

CPhI Worldwide 2021

Fiera Milano, Milan, Italy

9-11 November 2021

Book a meeting
View Our Exhibitor Profile

Contact information




View All Contact Info

Top Products

Our Resources

Categories affiliated with Geropharm